SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
Datum | Rating | Analyst | |
---|---|---|---|
06.09.12 | Novartis neutral | Exane-BNP Paribas SA | |
05.09.12 | Novartis reduce | Vontobel Research | |
04.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
03.09.12 | Novartis reduce | Vontobel Research | |
03.09.12 | Novartis kaufen | Die Actien-Börse | |
31.08.12 | Novartis buy | Deutsche Bank AG | |
31.08.12 | Novartis neutral | J.P. Morgan Cazenove | |
31.08.12 | Novartis buy | Sarasin Research | |
30.08.12 | Novartis reduce | Vontobel Research | |
29.08.12 | Novartis neutral | Citigroup Corp. | |
28.08.12 | Novartis buy | Deutsche Bank AG | |
28.08.12 | Novartis reduce | Vontobel Research | |
27.08.12 | Straumann reduce | Commerzbank Corp. & Markets | |
27.08.12 | Novartis reduce | Vontobel Research | |
24.08.12 | Novartis neutral | Exane-BNP Paribas SA | |
22.08.12 | Straumann neutral | UBS AG | |
22.08.12 | Straumann neutral | Nomura | |
22.08.12 | Straumann underperform | Cheuvreux SA | |
22.08.12 | Straumann underperform | Exane-BNP Paribas SA | |
22.08.12 | Straumann hold | Vontobel Research | |
21.08.12 | Straumann neutral | Sarasin Research | |
21.08.12 | COLTENE hold | Vontobel Research | |
20.08.12 | Novartis neutral | Goldman Sachs Group Inc. | |
17.08.12 | Straumann neutral | Nomura | |
17.08.12 | Tecan (N) buy | UBS AG | |
17.08.12 | Tecan (N) hold | Vontobel Research | |
17.08.12 | Basilea Pharmaceutica hold | Vontobel Research | |
17.08.12 | COLTENE hold | Vontobel Research | |
16.08.12 | Basilea Pharmaceutica buy | Sarasin Research | |
16.08.12 | Basilea Pharmaceutica hold | Vontobel Research | |
16.08.12 | Tecan (N) hold | Vontobel Research | |
16.08.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
15.08.12 | Novartis buy | Nomura | |
14.08.12 | Straumann hold | Vontobel Research | |
10.08.12 | Straumann underperform | Exane-BNP Paribas SA | |
10.08.12 | Lonza neutral | J.P. Morgan Cazenove | |
30.07.12 | Novartis hold | Vontobel Research | |
26.07.12 | Lonza neutral | UBS AG | |
26.07.12 | Straumann neutral | UBS AG | |
26.07.12 | Lonza hold | Vontobel Research |